In a cell-based non-invasive prenatal test (cbNIPT), intact circulating trophoblasts (CTs) are isolated from maternal blood for subsequent genetic analysis. Enrichment of these CTs from maternal blood is the most challenging step in the cbNIPT workflow. This study aims to assess the suitability of the filtration-based Metacell® technology to enrich CTs from maternal blood at week 10 to 13 of gestation. The Metacell® technology is a novel size-based enrichment technology that combines blood filtration through 8 μm pores with an in vitro culture method. Three protocols were evaluated. First, 8 mL or 16 mL of maternal blood was filtered and subsequently cultured in vitro on the separation membrane for 3 days in RPMI 1640. In addition, 16 mL of maternal blood was filtered, and immediately processed without further culturing. Y-chromosome-specific qPCR or STR analysis was performed to evaluate the enrichment of CTs. A total of 44 samples from pregnant women, out of which 26 were carrying a male fetus, were processed. Although five enriched male fetus samples show detectable male DNA quantities, it cannot be excluded that the obtained positive signal is caused by cell-free fetal DNA sticking to the Metacell® separation membrane. In conclusion, the Metacell® technology, tested as described, is not suitable for consistent enrichment of CTs.

Faculty Hospital Královské Vinohrady Laboratory Diagnostics Prague Czech Republic

Laboratory of Pharmaceutical Biotechnology Ghent University Ghent Belgium

Obstetrics and gynecology Ghent University Hospital Ghent Belgium

Zobrazit více v PubMed

Hartwig T. S., Ambye L., Sørensen S., and Jørgensen F. S., “Discordant non-invasive prenatal testing (NIPT)–a systematic review,” Prenatal Diagnosis, vol. 37, no. 6, pp. 527–539, 2017, doi: 10.1002/pd.5049 PubMed DOI

Warsof S. L., Larion S., and Abuhamad A. Z., “Overview of the impact of noninvasive prenatal testing on diagnostic procedures,” Prenatal Diagnosis, vol. 35, no. 10, pp. 972–979, 2015, doi: 10.1002/pd.4601 PubMed DOI

Brady P. et al., “Clinical implementation of NIPT—technical and biological challenges,” Clinical Genetics, vol. 89, no. 5, pp. 523–530, 2016, doi: 10.1111/cge.12598 PubMed DOI

Koumbaris G. et al., “Targeted capture enrichment followed by NGS: Development and validation of a single comprehensive NIPT for chromosomal aneuploidies, microdeletion syndromes and monogenic diseases,” Molecular Cytogenetics, vol. 12, no. 1, pp. 1–9, 2019, doi: 10.1186/s13039-019-0459-8 PubMed DOI PMC

Malcher C. et al., “Development of a comprehensive noninvasive prenatal test,” Genetics and Molecular Biology, vol. 41, no. 3, pp. 545–554, 2018, doi: 10.1590/1678-4685-GMB-2017-0177 PubMed DOI PMC

Liu L., Li K., Fu X., Chung C., and Zhang K., “A Forward Look At Noninvasive Prenatal Testing,” Trends in Molecular Medicine, vol. 22, no. 11, pp. 958–968, 2016, doi: 10.1016/j.molmed.2016.09.008 PubMed DOI

Srebniak M. I. et al., “Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis,” Ultrasound in Obstetrics and Gynecology, vol. 51, no. 4, pp. 445–452, 2018, doi: 10.1002/uog.17533 PubMed DOI

Shaffer B. L. and Norton M. E., “Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes,” Obstetrics and Gynecology Clinics of North America, vol. 45, no. 1, pp. 13–26, 2018, doi: 10.1016/j.ogc.2017.10.001 PubMed DOI

Wang J. et al., “Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women,” Annals of Translational Medicine, vol. 7, no. 14, pp. 319–319, 2019, doi: 10.21037/atm.2019.06.70 PubMed DOI PMC

Vestergaard E. M. et al., “On the road to replacing invasive testing with cell-based NIPT: Five clinical cases with aneuploidies, microduplication, unbalanced structural rearrangement, or mosaicism,” Prenatal Diagnosis, vol. 37, no. 11, pp. 1120–1124, 2017, doi: 10.1002/pd.5150 PubMed DOI

Fiddler M., “Fetal Cell Based Prenatal Diagnosis: Perspectives on the Present and Future,” Journal of Clinical Medicine, 2014, doi: 10.3390/jcm3030972 PubMed DOI PMC

Mouawia H. et al., “Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy,” Reproductive BioMedicine Online, 2012, doi: 10.1016/j.rbmo.2012.08.002 PubMed DOI

Pavličev M. et al., “Single-cell transcriptomics of the human placenta: Inferring the cell communication network of the maternal-fetal interface,” Genome Research, 2017, doi: 10.1101/gr.207597.116 PubMed DOI PMC

Borbely A. U. et al., “The term basal plate of the human placenta as a source of functional extravillous trophoblast cells,” Reproductive Biology and Endocrinology, 2014, doi: 10.1186/1477-7827-12-7 PubMed DOI PMC

Ravn K. et al., “The Number of Circulating Fetal Extravillous Trophoblasts Varies from Gestational Week 6 to 20,” Reproductive Sciences, vol. 27, no. 12, pp. 2170–2174, 2020, doi: 10.1007/s43032-020-00243-1 PubMed DOI PMC

Hatt L. et al., “Characterization of fetal cells from the maternal circulation by microarray gene expression analysis—Could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis?,” Fetal Diagnosis and Therapy, 2014, doi: 10.1159/000356073 PubMed DOI

Cho S., Yu H. J., Han J., Kim Y., Lee J., and Lee S. D., “Forensic application of SNP-based resequencing array for individual identification,” Forensic Science International: Genetics, vol. 13, pp. 45–52, 2014, doi: 10.1016/j.fsigen.2014.07.005 PubMed DOI

Kølvraa S. et al., “Genome-wide copy number analysis on DNA from fetal cells isolated from the blood of pregnant women,” Prenatal Diagnosis, 2016, doi: 10.1002/pd.4948 PubMed DOI

Hou S. et al., “Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts: Toward Noninvasive Prenatal Diagnostics,” ACS Nano, 2017, doi: 10.1021/acsnano.7b03073 PubMed DOI PMC

Chang L. et al., “A novel method for noninvasive diagnosis of monogenic diseases from circulating fetal cells,” Prenatal Diagnosis, 2020, doi: 10.1002/pd.5796 PubMed DOI

Vossaert L. et al., “Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis,” American Journal of Human Genetics, 2019, doi: 10.1016/j.ajhg.2019.11.004 PubMed DOI PMC

Desitter I. et al., “A new device for rapid isolation by size and characterization of rare circulating tumor cells,” Anticancer Research, 2011. PubMed

Hvichia G. E. et al., “A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells,” International Journal of Cancer, 2016, doi: 10.1002/ijc.30007 PubMed DOI PMC

Mouawia H. et al., “Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy,” Reproductive BioMedicine Online, 2012, doi: 10.1016/j.rbmo.2012.08.002 PubMed DOI

Vander Plaetsen A. S., Weymaere J., Tytgat O., Buyle M., Deforce D., and Van Nieuwerburgh F., “Enrichment of circulating trophoblasts from maternal blood using laminar microscale vortices,” Prenatal Diagnosis, 2021, doi: 10.1002/pd.5901 PubMed DOI PMC

Winter M. et al., “Isolation of Circulating Fetal Trophoblasts Using Inertial Microfluidics for Noninvasive Prenatal Testing,” Advanced Materials Technologies, 2018, doi: 10.1002/admt.201800066 DOI

Kolostova K. et al., “Molecular characterization of circulating tumor cells in ovarian cancer,” American Journal of Cancer Research, 2016. PubMed PMC

Kolostova K., Cegan M., and Bobek V., “Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture,” Journal of the Canadian Urological Association, 2014, doi: 10.5489/cuaj.1978 PubMed DOI PMC

Bobek V. and Kolostova K., “Isolation and characterization of CTCs from patients with cancer of a urothelial origin,” in Methods in Molecular Biology, 2018. doi: 10.1007/978-1-4939-7234-0_20 PubMed DOI

Kiss I. et al., “Circulating Endometrial Cells in Women With Spontaneous Pneumothorax,” Chest, 2020, doi: 10.1016/j.chest.2019.09.008 PubMed DOI

Bobek V., Kolostova K., and Kucera E., “Circulating endometrial cells in peripheral blood,” European Journal of Obstetrics and Gynecology and Reproductive Biology, 2014, doi: 10.1016/j.ejogrb.2014.07.037 PubMed DOI

Pospisilova E. et al., “Circulating Endometrial Cells: A New Source of Information on Endometriosis Dynamics,” Journal of Clinical Medicine, 2019, doi: 10.3390/jcm8111938 PubMed DOI PMC

Picchiassi E., Coata G., Fanetti A., Centra M., Pennacchi L., and Di Renzo G. C., “The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma,” Prenatal Diagnosis, 2008, doi: 10.1002/pd.2018 PubMed DOI

Ruijter J. M. et al., “Amplification efficiency: Linking baseline and bias in the analysis of quantitative PCR data,” Nucleic Acids Research, 2009, doi: 10.1093/nar/gkp045 PubMed DOI PMC

Dean L., “Chapter 1, Blood and the cells it contains,” in Blood Group and Red Cell Antigens (Internet), 2005.

Forootan A., Sjöback R., Björkman J., Sjögreen B., Linz L., and Kubista M., “Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR),” Biomolecular Detection and Quantification, 2017, doi: 10.1016/j.bdq.2017.04.001 PubMed DOI PMC

Laget S. et al., “Technical insights into highly sensitive isolation and molecular characterization of fixed and live circulating tumor cells for early detection of tumor invasion,” PLoS ONE, 2017, doi: 10.1371/journal.pone.0169427 PubMed DOI PMC

Hatt L. et al., “A new marker set that identifies fetal cells in maternal circulation with high specificity,” Prenatal Diagnosis, 2014, doi: 10.1002/pd.4429 PubMed DOI

van de Looij A. et al., “Do fetal extravillous trophoblasts circulate in maternal blood postpartum?,” Acta Obstetricia et Gynecologica Scandinavica, 2020, doi: 10.1111/aogs.13880 PubMed DOI PMC